The FRONTIER Study will determine the effectiveness of an emergency drug called NA-1 in reducing brain damage and disabilities in patients experiencing an acute stroke.
Currently, paramedics use a provincial stroke protocol to identify eligible patients and transport them to a stroke care centre. All stroke patients will continue to receive the current standard of care. In addition, the FRONTIER study is designed to examine whether a drug known as NA-1 will minimize the impact of a stroke when given by paramedics. Once in hospital, patients will continue to receive standard stroke care.
The study involves paramedics in Richmond and Vancouver as well as the stroke centre at Vancouver General Hospital. It is supported by a Multi-Investigator Research Initiative grant from the Brain Canada Foundation and sponsored by NoNO Inc.